NRX Therapeutics | 1.91 +0.23 +13.69% | ||
| NRXP | |||
| 高 1.92 | 开 1.72 | 量 52.84万股 | 总市值 5654.58万 |
| 低 1.71 | 换 1.78% | 额 96.40万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
NRX Therapeutics(NRXP)
2025-12-23 19:05
$NRX Pharmaceuticals(NRXP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003879 Act: 33 Size: 1 KB 网页链接
NRX Therapeutics(NRXP)
02-03 06:25
$NRX Therapeutics(NRXP)$ 8-K Current report, item 5.02 Accession Number: 0001437749-26-002682 Act: 34 Size: 178 KB 网页链接
NRX Therapeutics(NRXP)
01-17 06:15
$NRX Therapeutics(NRXP)$ 8-K Current report, items 3.01, 7.01, 8.01, and 9.01 Accession Number: 0001437749-26-001455 Act: 34 Size: 208 KB 网页链接
NRX Therapeutics(NRXP)
2025-11-15 05:45
$NRX Pharmaceuticals(NRXP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-25-035210 Act: 34 Size: 14 MB 网页链接
NRX Therapeutics(NRXP)
2025-11-27 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001437749-25-036452 Act: 34 Size: 247 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-13 05:35
$NRX Pharmaceuticals(NRXP)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001437749-25-037734 Act: 33 Size: 685 KB 网页链接
NRX Therapeutics(NRXP)
2025-11-22 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001437749-25-036005 Act: 34 Size: 1 MB 网页链接
NRX Therapeutics(NRXP)
2025-12-23 06:25
$NRX Pharmaceuticals(NRXP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-25-038563 Act: 33 Size: 340 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-30 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-25-038835 Act: 34 Size: 275 KB 网页链接